RxPG News XML Feed for RxPG News   Add RxPG News Headlines to My Yahoo!  

Medical Research Health Special Topics World
 
  Home
 
 Careers 
 Dental
 Medical
 Nursing
 
 Latest Research 
 Aging
 Anaethesia
 Biochemistry
 Biotechnology
 Cancer
 Cardiology
 Clinical Trials
 Cytology
 Dental
 Dermatology
 Embryology
 Endocrinology
 ENT
 Environment
 Gastroenterology
 Genetics
 Gynaecology
 Haematology
 Immunology
 Infectious Diseases
 Metabolism
 Microbiology
 Musculoskeletal
 Nephrology
 Neurosciences
 Obstetrics
 Ophthalmology
 Orthopedics
 Paediatrics
 Pathology
 Pharmacology
 Physiology
 Psychiatry
 Public Health
 Radiology
 Rheumatology
 Surgery
 Urology
 Alternative Medicine
 Medicine
 Epidemiology
 Sports Medicine
 Toxicology
 
 Medical News 
 Awards & Prizes
 Epidemics
 Health
 Healthcare
 Launch
 Opinion
 Professionals
 
 Special Topics 
 Ethics
 Euthanasia
 Evolution
 Feature
 Odd Medical News
 Climate
 
 DocIndia 
 Reservation Issue
 Overseas Indian Doctor

Last Updated: May 20, 2007 - 10:48:48 AM
News Report
Europe Channel

subscribe to Europe newsletter
Europe

   EMAIL   |   PRINT
Aspirin could lower bowel cancer risk
May 13, 2007 - 2:37:23 PM
Andrew Chan, of the gastrointestinal unit at Massachusetts General Hospital, Boston, said the results 'provide convincing evidence that aspirin, at biologically relevant doses, can reduce the incidence of colorectal cancer'.

Article options
 Email to a Friend
 Printer friendly version
 Europe channel RSS
 More Europe news
[RxPG] London, May 13 - A daily dose of common pain killer aspirin could cut the risk of getting bowel cancer by more than a third, says a new study. However, scientists do not recommend its continuous use due to possible side effects.

Bowel cancer refers to malignant tumours in the lower end of the gastro-intestinal tract. About 80 percent of bowel cancers occur in the large intestine and 20 percent in the rectum, with anal cancer being rare.

An Oxford University study showed that taking one 300 mg tablet a day for more than five years reduced the incidence of the disease, reported the online edition of Daily Mail.

Millions of people across the world are already taking small doses of aspirin every day to reduce the chance of suffering a second heart attack or stroke.

However, the painkiller can have serious side effects, including stomach bleeding. Researchers have warned in The Lancet medical journal that widespread use of aspirin as a preventive treatment against bowel cancer was not recommended.

But they argued that the potential benefits might outweigh the dangers for those at increased risk of the disease through family history or other factors.

Andrew Chan, of the gastrointestinal unit at Massachusetts General Hospital, Boston, said the results 'provide convincing evidence that aspirin, at biologically relevant doses, can reduce the incidence of colorectal cancer'.

He added: 'However, with the concerns about the potential risks of long-term aspirin use and the availability of alternative prevention strategies such as screening, these findings are not sufficient to warrant a recommendation for the general population to use aspirin for cancer prevention.'





Related Europe News
Moore returns to Cannes with scathing look at healthcare
India section kicks off at Cannes
Nesta extends contract with AC Milan until 2011
Federer, Nadal roll on into Hamburg semis
Fingerprint could identify smoker, drinker
Devil or wily lawyer - Cannes film looks at Jacques Verges
French president unveils new cabinet
'Blair could be in run for World Bank top job'
India's growing economic clout high on Brown's agenda
Roma snatch Italian Cup from Inter

Subscribe to Europe Newsletter
E-mail Address:

 Feedback
For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 
© All rights reserved 2004 onwards by RxPG Medical Solutions Private Limited
Contact Us